Clinical Effects of Tooth Powder on Gingivitis

NCT ID: NCT01902095

Last Updated: 2013-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

154 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-11-30

Study Completion Date

2011-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dental plaque, known as dental biofilm, is implicated as the primary etiological agent responsible for oral inflammatory diseases. Matured form of dental plaque plays a major role in the pathogenicity of gingivitis; if not managed in early stages it results in a cascade of events leading to the destruction of periodontal tissues.

Effective plaque control techniques have been suggested that maintain dental biofilm at levels compatible with oral health and is the cornerstone for all preventive strategies to control oral diseases particularly gingivitis. To clean teeth and ensure effective plaque control, different mechanical means have been in use since centuries. However because of an inadequacy in plaque removal, different antimicrobial and antiplaque agents have been introduced in oral-care products.

The use of dentifrices has been recommended over the years as the ultimate way of preventing the incidence of oral diseases. Dentifrices have the anti-plaque and the anti-gingivitis capabilities due to their composition. Toothpastes and to a lesser extent toothpowders are common oral-care products used to eliminate plaque and other deposits from tooth surfaces. Existent literature has focused more on toothpaste and mouth rinse and derelicts toothpowder despite its difference owing to the absence of humectants. With the intention to advance the knowledge on this issue as well as close the research gap, this study was conducted to evaluate the efficacy of toothpowder in alleviating gingivitis, controlling dental plaque, and inhibiting extrinsic stains.

A single-blind, parallel arm randomized controlled trial (RCT) evaluated the efficacy of toothpowder against toothpaste through oral hygiene parameters of plaque and stain deposits on teeth and gingival inflammation. Plaque Index, Lobene Stain Index and Gingival Index were used as measures of oral hygiene.

The current RCT revealed that toothpowder and toothpaste were equally effective in both treatment and control groups from clinical perspective however toothpowder showed a statistically significant effectiveness as compared to toothpaste. Toothpowder, composed of calcium carbonate and essential oils, has demonstrated to be statistically more effective than toothpaste in controlling extrinsic dental staining, dental plaque and gingival inflammation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A single-blind randomized controlled trial was conducted during November 2010 and October 2011. After screening and consent, eligible subjects received mechanical periodontal therapy. Subjects were then randomized to Test group and Control group at a 1:1 ratio. The test group was provided tooth powder and a control group received toothpaste. Healthy subjects with plaque induced gingivitis and who fulfilled the inclusion criteria were recruited from the Department of Periodontology, Fatima Jinnah Dental College Hospital, Karachi, Pakistan.77 subjects with gingivitis were randomized to test group and 77 subjects to the control group. Therefore, to complete the randomized controlled trial, a total of 154 subjects were recruited and randomized.

Outcome measure gingivitis was measured through plaque index, gingival index and Lobene stain index.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gingivitis Mouth Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tooth powder (test) arm

Experimental arm: tooth powder

Group Type EXPERIMENTAL

Tooth powder

Intervention Type DEVICE

Each participant was handed over a sealed pack containing a teeth cleaning kit that included tooth powder (test) or toothpaste (control) and a new soft toothbrush along with written and verbal instructions of usage. They were advised to brush their teeth twice a day with the given dentifrices and tooth brush for two weeks.

Tooth Paste (control)

Tooth Paste

Group Type ACTIVE_COMPARATOR

Tooth paste (control)

Intervention Type DEVICE

Active Comparator

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tooth powder

Each participant was handed over a sealed pack containing a teeth cleaning kit that included tooth powder (test) or toothpaste (control) and a new soft toothbrush along with written and verbal instructions of usage. They were advised to brush their teeth twice a day with the given dentifrices and tooth brush for two weeks.

Intervention Type DEVICE

Tooth paste (control)

Active Comparator

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Tooth paste

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female
2. Age ≥ 18-to-65 years (18th birthday completed)
3. In good general health
4. Available for the duration of the study
5. Able and willing to follow study protocol
6. Able and willing to sign approved informed consent
7. At least 20 natural teeth suitable for evaluation
8. Full mouth Gingival Index (GI) score ≥ 1.04

Exclusion Criteria

1. Females disagree to birth control measure for the duration of the study
2. Having any acute /chronic systemic illness
3. Current smokers or tobacco users
4. Pregnant or lactating Females
5. Allergy to the ingredients of the products to be tested
6. Requiring pre-medication prior to dental appointment
7. Antibiotic use in the last 3 months
8. Routine use of anticoagulant medication
9. Routine use of anti-inflammatory medication
10. Routine use of medications known to have effects on the gingiva e.g., phenytoin etc)
11. Routine use of medications inhibiting or stimulating salivary flow
12. Physical handicap that could interfere with daily performance of oral hygiene
13. Participation in any other study during the study period of this trial
14. Routine use of any mouthrinse
15. Routine use of any interdental cleaning device (floss, dental toothpicks)
16. Having any removable appliance
17. Having fixed orthodontic appliances (including permanent orthodontic retainers)
18. Having probing depth ≥4 mm at any site
19. Having had active periodontal therapy during the last 6 months
20. Had periodontal prophylaxis or periodontal maintenance therapy in the last 3 months
21. More than 3 carious lesions requiring immediate care
22. Gross oral pathology (e.g., tumors, candidiasis, mucocutaneous disease)
Minimum Eligible Age

33 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fatima Jinnah Dental College

OTHER

Sponsor Role collaborator

Sheikh Zayed Federal Postgraduate Medical Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Muhammad Khalil Khan

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ayyaz A Khan, PhD

Role: STUDY_DIRECTOR

University of the Punjab

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KhanMK-2012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.